| -1.00 / -4.10%|
The 7 analysts offering 12-month price forecasts for ACADIA Pharmaceuticals Inc have a median target of 26.00, with a high estimate of 28.00 and a low estimate of 20.00. The median estimate represents a +11.16% increase from the last price of 23.39.
The current consensus among 7 polled investment analysts is to Buy stock in ACADIA Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.